Literature DB >> 7533494

E-selectin expression in salivary endothelial cells and sera from patients with systemic sclerosis. Role of resident mast cell-derived tumor necrosis factor alpha.

M Hebbar1, P Lassalle, A Janin, D Vanhée, S Bisiau, P Y Hatron, A B Tonnel, B Gosselin.   

Abstract

OBJECTIVE: To assess endothelial cell activation in patients with systemic sclerosis (SSc).
METHODS: Concomitant study of salivary gland biopsy tissues and sera for expression of E-selectin and its potent activator tumor necrosis factor alpha (TNF alpha), using immunostaining and enzyme-linked immunosorbent essay.
RESULTS: E-selectin was overexpressed in SSc patients, but not in controls. TNF alpha was detected in mast cells.
CONCLUSION: Mast cell-derived TNF alpha may contribute to endothelial cell activation in SSc.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7533494     DOI： 10.1002/art.1780380318

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


  13 in total

Review 1.  Anti-endothelial cell antibodies in systemic sclerosis.

Authors:  Y Renaudineau; R Revelen; Y Levy; K Salojin; B Gilburg; Y Shoenfeld; P Youinou
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

Review 2.  Central nervous system mechanisms in Sjögren's syndrome.

Authors:  O P van Bijsterveld; A A Kruize; R L A W Bleys
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

3.  Mast cells, extracellular matrix components, TGFbeta isoforms and TGFbeta receptor expression in labial salivary glands in systemic sclerosis.

Authors:  G I Mason; J Hamburger; J B Matthews
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

4.  Assessment of anti-endothelial cell antibodies in systemic sclerosis and Sjögren's syndrome.

Authors:  M Hebbar; P Lassalle; Y Delneste; P Y Hatron; B Devulder; A B Tonnel; A Janin
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

Review 5.  Clinical use of the measurement of soluble cell adhesion molecules in patients with autoimmune rheumatic diseases.

Authors:  P P Sfikakis; G C Tsokos
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

Review 6.  Association between systemic sclerosis and breast cancer: eight new cases and review of the literature.

Authors:  David Launay; Rozenn Le Berre; Pierre-Yves Hatron; Jean-Philippe Peyrat; Eric Hachulla; Bernard Devulder; Mohamed Hebbar
Journal:  Clin Rheumatol       Date:  2004-12       Impact factor: 2.980

7.  Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis.

Authors:  M Hebbar; P Jeannin; G Magistrelli; P-Y Hatron; E Hachulla; B Devulder; J-Y Bonnefoy; Y Delneste
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

Review 8.  Is scleroderma a vasculopathy?

Authors:  Jo Nadine Fleming; Richard A Nash; William M Mahoney; Stephen Mark Schwartz
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

9.  Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement.

Authors:  Anna Kuryliszyn-Moskal; Piotr Adrian Klimiuk; Stanislaw Sierakowski
Journal:  Clin Rheumatol       Date:  2004-09-03       Impact factor: 2.980

10.  Prediction of residual valvular lesions in rheumatic heart disease: role of adhesion molecules.

Authors:  Mona Hafez; Sohier Yahia; Waleed Eldars; Heba Eldegla; Mohamed Matter; Gehan Attia; Samia Hawas
Journal:  Pediatr Cardiol       Date:  2012-09-18       Impact factor: 1.655
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.